OncLive TV

Short, focused interviews with key oncology thought leaders. This unique platform allows oncology professionals to learn about important developments directly from their peers.

Dr. Kasi on Utility of Personalized Medicine in Colorectal Cancer

Dr. Moore on Benefit of Mirvetuximab Soravtansine in Ovarian Cancer

Dr. Choti on Future Treatment of Patients With Stage IV Pancreatic Cancer

Dr. Schmid on Activity With Neoadjuvant Pembrolizumab in TNBC

Dr. Pagel on the ELEVATE-TN Trial in CLL

$Dr. Wang on the ZUMA-2 Trial in Relapsed/Refractory MCL$

Dr. Wang on the ZUMA-2 Trial in Relapsed/Refractory MCL

Incorporating Precision Medicine into Oncology

Dr. Dunavin on Frontline Treatment in Myelofibrosis

Dr. Moskowitz on Important Updates in Hodgkin Lymphoma

Next Page >>

Hundreds of the top oncologists and cancer researchers have conducted interviews with OncLive, which has contributed to a library of thousands of videos. To browse these interviews by the oncologist's names, click here >>>

Featured

Recent Updates in HER2+ Breast Cancer

Updates in HER2-positive breast cancer that were presented at the 2019 San Antonio Breast Cancer Symposium.

View more >>>

Featured

Emerging MOAs in Multiple Myeloma: Updates From the 17th IMW

Data and analysis shared at the 17th International Myeloma Workshop show that anti-BCMA directed treatments, including CAR T-cell therapy, bispecific antibodies, and antibody-drug conjugates have the potential to revolutionize the multiple myeloma treatment paradigm.

View more >>>

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approvals in Urothelial Cancer and GIST, Promising Data in Urothelial Carcinoma, and More